person · Reporting owner
SATTERTHWAITE LIVINGSTON
Disclosed activity across 4 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Amprius Technologies, Inc.AMPX · Entity 4742 | Director | June 12, 2026 | June 16, 2026 |
| Chemours CoCC · Entity 4420 | Director | May 06, 2026 | May 08, 2026 |
| ERock, Inc.EROC · Entity 4204 | Director | June 11, 2026 | June 12, 2026 |
| IDEX CORP /DE/IEX · Entity 3323 | Director | May 07, 2024 | May 08, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Amprius Technologies, Inc.
Report date June 12, 2026 · Filed June 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 346,506 |
Reported balance
After 2026-06-12 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-12 · Grant · Acquired 10,423 · Balance 346,506 F1: The securities are represented by restricted stock units. Each restricted stock unit represents the reporting person's right to receive one share of issuer's common stock. 100% of the restricted stock units vest on the earlier of (i) the one-year anniversary of the date the restricted stock units were granted and (ii) the day before the next annual meeting of stockholders, subject to the reporting person's continued service as of the vesting date. F2: Includes 199,102 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. |
Filing footnotes · ownership attribution and instrument terms
F1: The securities are represented by restricted stock units. Each restricted stock unit represents the reporting person's right to receive one share of issuer's common stock. 100% of the restricted stock units vest on the earlier of (i) the one-year anniversary of the date the restricted stock units were granted and (ii) the day before the next annual meeting of stockholders, subject to the reporting person's continued service as of the vesting date.
F2: Includes 199,102 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock, subject to the applicable vesting schedule and conditions of each restricted stock unit.
Chemours Co
Report date May 06, 2026 · Filed May 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 30,807.855 |
Reported balance
After 2026-05-06 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-06 · Grant · Acquired 7,182 · Balance 30,807.855 F1: Represents stock units that will convert one-for-one to Chemours common stock upon separation from service on the Board. F2: Includes deferred stock units and dividend equivalent units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents stock units that will convert one-for-one to Chemours common stock upon separation from service on the Board.
F2: Includes deferred stock units and dividend equivalent units.
ERock, Inc.
Report date June 11, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 13,024 |
Reported balance
After 2026-06-11 transaction · row 1
1 source rowRow 1 · 2026-06-11 · Grant · Acquired 13,024 · Balance 13,024 F1: Consists of 13,024 restricted stock units granted to the Reporting Person, which will vest on the earlier of the first anniversary of the grant date or the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the right to receive one share of Class A common stock of the Issuer following vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of 13,024 restricted stock units granted to the Reporting Person, which will vest on the earlier of the first anniversary of the grant date or the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the right to receive one share of Class A common stock of the Issuer following vesting.
IDEX CORP /DE/
Report date May 07, 2024 · Filed May 08, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| COMMON STOCKSEC Table I · non-derivative | Direct | 14,747 |
Reported balance
After 2024-05-07 transaction · row 1
1 source rowRow 1 · 2024-05-07 · Grant · Acquired 745 · Balance 14,747 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 12, 2026 Filed Jun 16, 2026 22:01 UTC | Amprius Technologies, Inc. AMPX · Entity 4742 | GrantCommon stock | 10,423 | $0.00 | $0.00 |
DisclosureSEC source: 0001517394-26-000003 · wk-form4_1781647282.xml · nonDerivative · entry 1 SATTERTHWAITE LIVINGSTON · CIK 0001517394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 346,506 F1 · shares: The securities are represented by restricted stock units. Each restricted stock unit represents the reporting person's right to receive one share of issuer's common stock. 100% of the restricted stock units vest on the earlier of (i) the one-year anniversary of the date the restricted stock units were granted and (ii) the day before the next annual meeting of stockholders, subject to the reporting person's continued service as of the vesting date. F2 · balance_after: Includes 199,102 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. Read SEC document |
| June 11, 2026 Filed Jun 12, 2026 22:15 UTC | ERock, Inc. EROC · Entity 4204 | GrantClass A Common Stock | 13,024 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-269840 · ownership.xml · nonDerivative · entry 1 SATTERTHWAITE LIVINGSTON · CIK 0001517394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,024 F1 · shares: Consists of 13,024 restricted stock units granted to the Reporting Person, which will vest on the earlier of the first anniversary of the grant date or the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the right to receive one share of Class A common stock of the Issuer following vesting. Read SEC document |
| May 06, 2026 Filed May 8, 2026 20:15 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 7,182 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-214660 · ownership.xml · nonDerivative · entry 1 SATTERTHWAITE LIVINGSTON · CIK 0001517394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,807.855 F1 · shares: Represents stock units that will convert one-for-one to Chemours common stock upon separation from service on the Board. F2 · balance_after: Includes deferred stock units and dividend equivalent units. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 22:41 UTC | Chemours Co CC · Entity 4420 | GrantDeferred Stock Units · Derivative | 1,298 | $11.79 | $15,303.42 |
DisclosureSEC source: 0001193125-26-002824 · ownership.xml · derivative · entry 1 SATTERTHWAITE LIVINGSTON · CIK 0001517394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,615.309 Underlying: Common Stock · 1,298 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit is the economic equivalent of one share of the Issuer's common stock. The deferred stock units become payable upon the second calendar year following the Reporting Person's termination of service as a director. F1 · derivative.exercise_date: Each deferred stock unit is the economic equivalent of one share of the Issuer's common stock. The deferred stock units become payable upon the second calendar year following the Reporting Person's termination of service as a director. F1 · derivative.expiration_date: Each deferred stock unit is the economic equivalent of one share of the Issuer's common stock. The deferred stock units become payable upon the second calendar year following the Reporting Person's termination of service as a director. F2 · balance_after: Includes deferred stock units and dividend equivalent units. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 14:42 UTC | Chemours Co CC · Entity 4420 | GrantDeferred Stock Units · Derivative | 966 | $15.84 | $15,301.44 |
DisclosureSEC source: 0001193125-25-227669 · ownership.xml · derivative · entry 1 SATTERTHWAITE LIVINGSTON · CIK 0001517394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,280.0507 Underlying: Common Stock · 966 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit is the economic equivalent of one share of the Issuer's common stock. The deferred stock units become payable upon the second calendar year following the Reporting Person's termination of service as a director. F1 · derivative.exercise_date: Each deferred stock unit is the economic equivalent of one share of the Issuer's common stock. The deferred stock units become payable upon the second calendar year following the Reporting Person's termination of service as a director. F1 · derivative.expiration_date: Each deferred stock unit is the economic equivalent of one share of the Issuer's common stock. The deferred stock units become payable upon the second calendar year following the Reporting Person's termination of service as a director. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:15 UTC | Chemours Co CC · Entity 4420 | GrantDeferred Stock Units · Derivative | 1,337 | $11.45 | $15,308.65 |
DisclosureSEC source: 0001062993-25-012445 · form4.xml · derivative · entry 1 SATTERTHWAITE LIVINGSTON · CIK 0001517394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,337 Underlying: Common Stock · 1,337 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit is the economic equivalent of one share of the Issuer's common stock. The deferred stock units become payable upon the second calendar year following the Reporting Person's termination of service as a director. F1 · derivative.exercise_date: Each deferred stock unit is the economic equivalent of one share of the Issuer's common stock. The deferred stock units become payable upon the second calendar year following the Reporting Person's termination of service as a director. F1 · derivative.expiration_date: Each deferred stock unit is the economic equivalent of one share of the Issuer's common stock. The deferred stock units become payable upon the second calendar year following the Reporting Person's termination of service as a director. Read SEC document |
| June 13, 2025 Filed Jun 18, 2025 00:19 UTC | Amprius Technologies, Inc. AMPX · Entity 4742 | GrantCommon stock | 44,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-031976 · wk-form4_1750205948.xml · nonDerivative · entry 1 SATTERTHWAITE LIVINGSTON · CIK 0001517394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 336,083 F1 · shares: The securities are represented by restricted stock units. Each restricted stock unit represents the reporting person's right to receive one share of issuer's common stock. 100% of the restricted stock units vest on the earlier of (i) the one-year anniversary of the date the restricted stock units were granted and (ii) the day before the next annual meeting of stockholders, subject to the reporting person's continued service as of the vesting date. F2 · balance_after: Includes 331,773 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. Read SEC document |
| April 22, 2025 Filed Apr 24, 2025 21:28 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 14,096 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-007922 · form4.xml · nonDerivative · entry 1 SATTERTHWAITE LIVINGSTON · CIK 0001517394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,029.9816 F1 · shares: Represents stock units that will convert one-for-one to Chemours common stock upon separation from service on the board. F2 · balance_after: Includes stock units and dividend equivalent units. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:32 UTC | Chemours Co CC · Entity 4420 | GrantDeferred Stock Units · Derivative | 970.0664 | $13.53 | $13,125.00 |
DisclosureSEC source: 0001062993-25-006841 · form4.xml · derivative · entry 1 SATTERTHWAITE LIVINGSTON · CIK 0001517394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 970.0664 Underlying: Common Stock · 970.0664 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit is the economic equivalent of one share of the Issuer's common stock. The deferred stock units become payable upon the second calendar year following the Reporting Person's termination of service as a director. F1 · derivative.exercise_date: Each deferred stock unit is the economic equivalent of one share of the Issuer's common stock. The deferred stock units become payable upon the second calendar year following the Reporting Person's termination of service as a director. F1 · derivative.expiration_date: Each deferred stock unit is the economic equivalent of one share of the Issuer's common stock. The deferred stock units become payable upon the second calendar year following the Reporting Person's termination of service as a director. Read SEC document |
| August 13, 2024 Filed Aug 14, 2024 21:32 UTC | Amprius Technologies, Inc. AMPX · Entity 4742 | GrantCommon stock | 283,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-037295 · wk-form4_1723671137.xml · nonDerivative · entry 1 SATTERTHWAITE LIVINGSTON · CIK 0001517394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 291,639 F1 · shares: The securities are represented by restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest in three equal annual installments on August 13, 2025, August 13, 2026 and August 13, 2027, subject to the reporting person's continued service on each applicable vesting date. F2 · balance_after: Includes 291,639 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. Read SEC document |
| August 06, 2024 Filed Aug 7, 2024 20:54 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 8,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-014616 · form4.xml · nonDerivative · entry 1 SATTERTHWAITE LIVINGSTON · CIK 0001517394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,547 F1 · shares: Represents stock units that will convert one-for-one to Chemours common stock upon separation from service on the board. F2 · balance_after: Includes stock units and dividend equivalent units. Read SEC document |
| May 07, 2024 Filed May 8, 2024 20:13 UTC | IDEX CORP /DE/ IEX · Entity 3323 | GrantCOMMON STOCK | 745 | $0.00 | $0.00 |
DisclosureSEC source: 0000832101-24-000026 · primary_doc.xml · nonDerivative · entry 1 SATTERTHWAITE LIVINGSTON · CIK 0001517394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,747 Read SEC document |
| May 25, 2023 Filed May 30, 2023 19:49 UTC | IDEX CORP /DE/ IEX · Entity 3323 | GrantCOMMON STOCK | 770 | $0.00 | $0.00 |
DisclosureSEC source: 0001842832-23-000008 · primary_doc.xml · nonDerivative · entry 1 SATTERTHWAITE LIVINGSTON · CIK 0001517394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,002 Read SEC document |
| November 02, 2022 Filed Nov 2, 2022 21:41 UTC | IDEX CORP /DE/ IEX · Entity 3323 | Exercise / conversionOPTIONS (RIGHT TO BUY) · Derivative | 3,075 | $0.00 Strike: $50.45 | $0.00 |
DisclosureSEC source: 0001913866-22-000001 · primary_doc.xml · derivative · entry 3 SATTERTHWAITE LIVINGSTON · CIK 0001517394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: COMMON STOCK · 3,075 shares Expires 2023-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2022 Filed Nov 2, 2022 21:41 UTC | IDEX CORP /DE/ IEX · Entity 3323 | SaleCOMMON STOCK | 3,075 | $222.69 | $684,766.22 |
DisclosureSEC source: 0001913866-22-000001 · primary_doc.xml · nonDerivative · entry 2 SATTERTHWAITE LIVINGSTON · CIK 0001517394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,232 Read SEC document |
| November 02, 2022 Filed Nov 2, 2022 21:41 UTC | IDEX CORP /DE/ IEX · Entity 3323 | Exercise / conversionCOMMON STOCK | 3,075 | $50.45 | $155,133.75 |
DisclosureSEC source: 0001913866-22-000001 · primary_doc.xml · nonDerivative · entry 1 SATTERTHWAITE LIVINGSTON · CIK 0001517394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,307 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2022 Filed May 10, 2022 17:21 UTC | IDEX CORP /DE/ IEX · Entity 3323 | GrantCOMMON STOCK | 825 | $0.00 | $0.00 |
DisclosureSEC source: 0000832101-22-000026 · primary_doc.xml · nonDerivative · entry 1 SATTERTHWAITE LIVINGSTON · CIK 0001517394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,232 Read SEC document |
| November 09, 2021 Filed Nov 12, 2021 16:33 UTC | IDEX CORP /DE/ IEX · Entity 3323 | Exercise / conversionOPTIONS (RIGHT TO BUY) · Derivative | 3,530 | $0.00 Strike: $42.86 | $0.00 |
DisclosureSEC source: 0001842788-21-000016 · primary_doc.xml · derivative · entry 3 SATTERTHWAITE LIVINGSTON · CIK 0001517394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: COMMON STOCK · 3,530 shares Expires 2022-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: On prior Forms 4, options held by this reporting person were reported on an aggregate basis in Column 9. As of this Form 4, the reporting person is separately reporting in Column 9 the number of options owned of each particular class. Read SEC document |
| November 09, 2021 Filed Nov 12, 2021 16:33 UTC | IDEX CORP /DE/ IEX · Entity 3323 | SaleCOMMON STOCK | 3,530 | $235.54 | $831,445.96 |
DisclosureSEC source: 0001842788-21-000016 · primary_doc.xml · nonDerivative · entry 2 SATTERTHWAITE LIVINGSTON · CIK 0001517394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,407 Read SEC document |
| November 09, 2021 Filed Nov 12, 2021 16:33 UTC | IDEX CORP /DE/ IEX · Entity 3323 | Exercise / conversionCOMMON STOCK | 3,530 | $42.86 | $151,295.80 |
DisclosureSEC source: 0001842788-21-000016 · primary_doc.xml · nonDerivative · entry 1 SATTERTHWAITE LIVINGSTON · CIK 0001517394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,937 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:32 UTC | IDEX CORP /DE/ IEX · Entity 3323 | GrantCOMMON STOCK | 665 | $0.00 | $0.00 |
DisclosureSEC source: 0001226577-21-000009 · primary_doc.xml · nonDerivative · entry 1 SATTERTHWAITE LIVINGSTON · CIK 0001517394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,407 Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 18:01 UTC | IDEX CORP /DE/ IEX · Entity 3323 | Exercise / conversionOPTIONS (RIGHT TO BUY) · Derivative | 4,800 | $0.00 Strike: $45.16 | $0.00 |
DisclosureSEC source: 0001842788-21-000007 · primary_doc.xml · derivative · entry 3 SATTERTHWAITE LIVINGSTON · CIK 0001517394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,605 Underlying: COMMON STOCK · 4,800 shares Expires 2021-04-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 18:01 UTC | IDEX CORP /DE/ IEX · Entity 3323 | SaleCOMMON STOCK | 4,800 | $197.26 | $946,833.12 |
DisclosureSEC source: 0001842788-21-000007 · primary_doc.xml · nonDerivative · entry 2 SATTERTHWAITE LIVINGSTON · CIK 0001517394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,742 Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 18:01 UTC | IDEX CORP /DE/ IEX · Entity 3323 | Exercise / conversionCOMMON STOCK | 4,800 | $45.16 | $216,768.00 |
DisclosureSEC source: 0001842788-21-000007 · primary_doc.xml · nonDerivative · entry 1 SATTERTHWAITE LIVINGSTON · CIK 0001517394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,542 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2020 Filed May 11, 2020 20:31 UTC | IDEX CORP /DE/ IEX · Entity 3323 | GrantCOMMON STOCK | 950 | $0.00 | $0.00 |
DisclosureSEC source: 0001574068-20-000009 · primary_doc.xml · nonDerivative · entry 1 SATTERTHWAITE LIVINGSTON · CIK 0001517394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,742 Read SEC document |
| May 10, 2019 Filed May 14, 2019 20:48 UTC | IDEX CORP /DE/ IEX · Entity 3323 | GrantCOMMON STOCK | 845 | $0.00 | $0.00 |
DisclosureSEC source: 0001226577-19-000007 · primary_doc.xml · nonDerivative · entry 1 SATTERTHWAITE LIVINGSTON · CIK 0001517394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,792 Read SEC document |
| April 25, 2018 Filed Apr 26, 2018 21:17 UTC | IDEX CORP /DE/ IEX · Entity 3323 | GrantCOMMON STOCK | 945 | $0.00 | $0.00 |
DisclosureSEC source: 0001226577-18-000005 · primary_doc.xml · nonDerivative · entry 1 SATTERTHWAITE LIVINGSTON · CIK 0001517394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,947 Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 23:56 UTC | IDEX CORP /DE/ IEX · Entity 3323 | GrantCOMMON STOCK | 1,290 | $0.00 | $0.00 |
DisclosureSEC source: 0001322851-17-000004 · primary_doc.xml · nonDerivative · entry 1 SATTERTHWAITE LIVINGSTON · CIK 0001517394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,002 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.